https://www.sec.gov/Archives/edgar/data/1425205/000110465926075778/iova-20260618xs3asr.htm

First T cell therapy for a solid tumor cancer and first treatment option approved in Australia for a

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovati

Chardan Capital analyst Geulah Livshits maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Bu

Iovance Biotherapeutics (NASDAQ:IOVA) sees FY2026 sales of $350.000 million-$370.000 million vs $370

Iovance Biotherapeutics (NASDAQ:IOVA) reported quarterly losses of $(0.19) per share which missed th

U.S. stock futures fall 250 points, Highpeak Energy shares drop 7%. Other stocks also down in pre-ma

U.S. stock futures fall 250 points, Highpeak Energy shares drop 7%. Other stocks also down in pre-ma

Iovance stock jumps despite no news as investors watch short interest and promising early data from

UBS analyst David Dai maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Neutral and raises t

Top Wall Street analysts changed outlook on top names. Check out all changes, including upgrades, do

Citizens analyst Reni J. Benjamin upgrades Iovance Biotherapeutics (NASDAQ:IOVA) from Market Perf

Barclays analyst Etzer Darout maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Overweight a

Citizens analyst Reni J. Benjamin upgrades Iovance Biotherapeutics (NASDAQ:IOVA) from Market Perf

Iovance shares jump 29% after early cancer trial shows 50% response rate. The company plans FDA talk

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a

Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session a

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter resu